NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 85 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71,433 | -18.7% | 17,508 | 0.0% | 0.00% | – |
| Q4 2022 | $87,890 | -59.6% | 17,508 | +5.3% | 0.00% | – |
| Q3 2022 | $217,403 | -0.0% | 16,621 | -2.0% | 0.00% | – |
| Q2 2022 | $217,466 | -3.0% | 16,963 | +15.4% | 0.00% | – |
| Q1 2022 | $224,114 | -29.1% | 14,696 | -17.7% | 0.00% | – |
| Q4 2021 | $316,000 | -15.1% | 17,864 | +1.1% | 0.00% | – |
| Q3 2021 | $372,000 | -0.5% | 17,676 | -6.8% | 0.00% | – |
| Q2 2021 | $374,000 | -17.8% | 18,968 | +21.3% | 0.00% | – |
| Q1 2021 | $455,000 | -3.2% | 15,641 | +0.8% | 0.00% | – |
| Q4 2020 | $470,000 | +95.8% | 15,518 | +3.0% | 0.00% | – |
| Q3 2020 | $240,000 | -18.6% | 15,071 | 0.0% | 0.00% | – |
| Q2 2020 | $295,000 | +43.2% | 15,071 | -9.6% | 0.00% | – |
| Q1 2020 | $206,000 | – | 16,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |